Interleukin-6 (IL-6) prevents activation-induced cell death: IL-2- independent inhibition of Fas/fasL expression and cell death

Blood

Volumn 92, Issue 11, 1998, Pages 4212-4219

  Ayroldi, Emira ^a   Zollo, Ornella ^b   Cannarile, Lorenza ^b   D'Adamio, Francesca ^b   Grohmann, Ursula ^b   Delfino, Domenico V ^b   Riccardi, Carlo ^b  

^a UNIVERSITY OF PERUGIA   (Italy)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

FAS ANTIGEN; INTERLEUKIN 2; INTERLEUKIN 6;

ANIMAL CELL; ARTICLE; CELL DEATH; CONTROLLED STUDY; CYTOKINE PRODUCTION; HYBRIDOMA; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; T LYMPHOCYTE; T LYMPHOCYTE ACTIVATION;

EID: 0032402144     PISSN: 00064971     EISSN: None     Source Type: Journal    
DOI: 10.1182/blood.v92.11.4212.423k42_4212_4219     Document Type: Article

References (51)

1. Crabtree GR: Contingent genetic regulatory events in T lymphocyte activation. Science 243:355, 1989
2. Kabelitz D, Pohl T, Pechhold K: Activation-induced cell death (apoptosis) of mature peripheral T lymphocytes. Immunol Today 14:338, 1993
3. Ju-ST, Panka DJ, Cui H, Ettinger R, el-Khatib M, Sherr DH, Stanger BZ, Marshak-Rothstein A: Fas(CD95)/FasL interactions required for programmed cell death after T-cell activation. Nature 373:444, 1995
4. Alderson MR, Tough TW, Davis-Smith T, Braddy S, Falk B, Schooley KA, Goodwin RG, Smith CA, Ramsdell F, Lynch DH: Fas ligand mediates activation-induced cell death in human T lymphocytes. J Exp Med 181:71, 1995
5. Dhein J, Walczak H, Bäumler C, Debatin KM, Krammer PH: Autocrine T-cell suicide mediated by APO-1/(Fas/CD95). Nature 373:438, 1995
6. Yonehara S, Ishii A, Yonehara M: A cell-killing monoclonal antibody (anti-Fas) to a cell surface antigen co-downregulated with the receptor of tumor necrosis factor. J Exp Med 169:1747, 1989
7. Itoh N, Yonehara S, Ishii A, Yonehara M, Mizushima S, Sameshima M, Hase A, Seto Y, Nagata S: The polypeptide encoded by the cDNA for human cell surface antigen Fas can mediate apoptosis. Cell 66:233, 1991
8. Suda T, Takahashi T, Golstein P, Nagata S: Molecular cloning and expression of the Fas ligand, a novel member of the tumor necrosis factor family. Cell 75:1169, 1993
9. Suda T, Okazaki T, Naito Y, Yokota T, Arai N, Ozaki S, Nakao K, Nagata S: Expression of the Fas ligand in cells of T cell lineage. J Immunol 154:3806, 1995
10. Lynch DH, Ramsdell F, Alderson MR: Fas and FasL in the homeostatic regulation of immune responses. Immunol Today 16:569, 1995
11. Ayroldi E, Cannarile L, Migliorati G, Bartoli A, Nicoletti I, Riccardi C: CD44 (Pgp-1) inhibits CD3 and dexamethasone-induced apoptosis. Blood 86:2672, 1995
12. Ayroldi E, Migliorati G, Cannarile L, Moraca R, Delfino DV, Riccardi C: CD2 rescues T cell from T-cell ReceptQr/CD3 apoptosis: a role for the Fas/Fns-L system. Blood 89:3717, 1997
13. Nieto MA, Gonzalez A, Lopez-Rivas A, Diaz-Espada F, Gambon F: IL-2 protects against anti-CD3-induced cell death in human medullary thymocytes. J Immunol 145:1364: 1990
14. Migliorati G, Nicoletti I, Pagliacci MC, D'Adamio L, Riccardi C: Interleukin-4 protects double-negative and CD4 single-positive thymocytes from dexamethasone-induced apoptosis. Blood 81:1352, 1993
15. Akbar AN, Salmon M, Savill J, Janossy G: A possible role for bcl-2 in regulating T-cell memory: a "balancing act" between cell death and survival. Immunol Today 14:526, 1993
16. Akbar AN, Borthwick N, Salmon M, Gombert W, Bofill M, Shamsadeen N, Pilling D, Pett S, Grundy JE, Janossy G: The significance of low bcl-2 expression by CD45RO T cells in normal individuals and patients with acute viral infections. The role of apoptosis in T cell memory. J Exp Med 178:427, 1993
17. Akbar AN, Borthwick NJ, Wickremasinghe RG, Panayoitidis P, Pilling D, Bofill M, Krajewski S, Reed JC, Salmon M: Interleukin-2 receptor common gamma-chain signaling cytokines regulate activated T cell apoptosis in response to growth factor withdrawal: Selective induction of anti-apoptotic (bcl-2, bcl-xL) but not pro-apoptotic (bax, bcl-xS) gene expression. Eur J Immunol 26:294, 1996
18. Strasser A, Harris AW, Cory S: Bcl-2 transgene inhibits T cell death and perturbs thymic self-censorship, Cell 67:889, 1991
19. Broome HE, Dargan CM, Krajewski S, Reed JC: Expression of Bcl-2, Bcl-x, and Bax after T cell activation and IL-2 withdrawal. J Immunol 155:2311, 1995
20. Lenardo MJ: Interleukin-2 programs mouse alpha beta T lymphocytes for apoptosis. Nature 353:858, 1991
21. Boehme SA, Lenardo MJ: Propriocidal apoptosis of mature T lymphocytes occurs at S phase of the cell cycle. Eur J Immunol 23:1552 1993
22. Van-Parijs L, Ibraghimov A, Abbas AK: The role of costimulation and Fas in T cell apoptosis and peripheral tolerance. Immunity 4:321, 1996
23. Lenardo MJ, Boehme S, Chen L, Combadiere B, Fisher G, Freedman M, McFarland H, Pelfrey C, Zheng L: Autocrine feedback death and the regulation of mature T lymphocyte antigen responses. Int Rev Immunol 13:115, 1995
24. Critchfield JM, Zuniga-Pflucker JC, Lenardo MJ: Parameters controlling the programmed death of mature mouse T lymphocytes in high-dose suppression. Cell Immunol 160:71, 1995
25. Critchfield JM, Lenardo MJ: Antigen-induced programmed T cell death as a new approach to immune therapy. Clin Immunol Immunopathol 75:13, 1995
26. Schorle H, Holtschke T, Hunig T, Schimpl A, Horak I: Development and function of T cells in mice rendered interleukin-2 deficient by gene targeting. Nature 352:621, 1991
27. Sadlack B, Merz H, Schorle H, Schimpl A, Feller A, Horak I: Ulcerative colitis-like disease in mice with a disrupted interleukin-2 gene. Cell 75:253, 1993
28. Horak I, Lohler J, Ma A, Smitt KA: Interleukin-2 deficient mice: A new model to study autoimmunity and self-tolerance. Immunol Rev 148:35, 1995
29. D'Adamio F, Zollo O, Moraca R, Ayroldi E, Bruscoli S, Bartoli A, Cannarile L, Migliorari G, Riccardi C: A new dexamethasone-induced gene of the leucin zipper family protects T lymphocytes from TCR/CD3-activated cell death. Immunity 7:803, 1997
30. Shimonkevitz R, Kappler J, Marrack P, Grey H: Antigen recognition by H-2-resctricted T cells. I. Cell-free antigen processing. J Exp Med 158:303, 1983
31. Nicoletti I, Migliorati G, Pagtiacci C, Grignani F, Riccardi C: A rapid and simple method for measuring thymocyte apoptosis by propidium iodide staining and flow cytometry. J Immunol Methods 139:271, 1991
32. Parren PW, Geerts ME, Boeije LC, Aarden LA: Induction of T-cell proliferation by recombinant mouse and chimeric mouse/human anti-CD3 monoclonal antibodies. Res Immunol 142:749, 1991
33. Nocentini G, Giunchi L, Ronchetti S, Krausz T, Bartoli A, Moraca R, Migliorati G, Riccardi C: A new member of the tumor necrosis factor/nerve growth factor receptor family inhibits T cell receptor-induced apoptosis. Proc Natl Acad Sci USA 94:6216, 1997
34. Theze J, Alzari PM, Bertoglio J: Interleukin 2 and its receptors: Recent advances and new immunological functions. Immunol Today 17:481, 1996
35. Meuer SC, Hussey R, Cantrell D, Hodgdon JC, Schlossman SF, Smith K, Reinherz E: Triggering of the T3-Ti antigen-receptor complex results in clonal T-cell proliferation trough an interleukin dependent autocrine pathway. Proc Natl Acad Sci USA 81:1509, 1984
36. Cantrell DA, Smith KA: The interleukin-2 T-cell system: A new cell growth model. Science 224:1312, 1984
37. Novelli F, Bernabei P, Ozmen L, Rigamonti L, Allione A, Pestka S, Garotta G, Forni G: Switching on of the proliferation or apoptosis of activated human T lymphocytes by IFN-gamma is correlated with the differential expression of the alpha- and beta-chains of its receptor. J Immunol 157:1935, 1996
38. Minty A, Chalon P, Derocq JM, Dumont X, Guillemot JC, Kaghad M, Labit C, Leplatois P, Liauzun P, Miloux B, Minty C, Casellas P, Loison G, Lupker J, Shire D, Ferrara P, Caput D: Interleukin-13 is a new human lymphokine regulating inflammatory and immune responses. Nature 362:248, 1993
39. Schwarze MM, Hawley RG: Prevention of myeloma cell apoptosis by ectopic bcl-2 expression or interleukin 6-mediated up-regulation of bcl-xL. Cancer Res 55:2262, 1995
40. Owen-Schaub LB, Yonehara S, Crump WL III, Grimm EA: DNA fragmentation and cell death is selectively triggered in activated human lymphocytes by Fas antigen engagement. Cell Immunol 140:197, 1992
41. Chauhan D, Kharbanda S, Ogata A, Urashima M, Teoh G, Robertson M, Kufe DW, Anderson KC: Interleukin-6 inhibits Fasinduced apoptosis and stress-activated protein kinase in multiple myeloma cells. Blood 89:227, 1997
42. Teague TK, Marrack P, Kappler JW, Vella AT: IL-6 rescues resting mouse T cells from apoptosis. J Immunol 158:5791, 1997
43. Hardin J, MacLeod S, Grigorieva I, Chang R, Barlogie B, Xiao H, Epstein J: Interleukin-6 prevents dexamethasone-induced myeloma cell death. Blood 84:3063, 1994
44. Tilg H, Dinarello CA, Mier JW: IL6 and APPs: Anti-inflammatory and immunosuppressive mediators. Immunol Today 18: 428, 1997
45. Baumann H, Gauldie J: The acute phase response (see comments). Immunol Today 15:74, 1994
46. Heuertz RM, Piquette CA, Webster RO: Rabbits with elevated serum C-reactive protein exhibit diminished neutrophil infiltration and vascular permeability in C5a-induced alveolitis. Am J Pathol 142:319, 1993
47. Abernathy VJ, Webster RO, Dahms TE: C-reactive protein inhibits increased pulmonary vascular permeability induced by FMLP in isolated rabbit lungs. Am J Physiol 271:507, 1996
48. Heuertz RM, Xia D, Samols D, Webster RO: Inhibition of C5a des Arg-induced neutrophil alveolitis in transgenic mice expressing C-reactive protein. Am J Physiol 266:649, 1994
49. Ahmed N, Thorley R, Xia D, Sumols D, Webster RO: Transgenic mice expressing rabbit C-reactive protein exhibit diminished chemotactic factor-induced alveolitis. Am J Respir Crit Care Med 153:1141, 1996
50. Heuertz RM, Ahmed N, Webster RO: Peptides derived from C-reactive protein inhibit neutrophil alveolitis. J Immunol 156:3412, 1996
51. Tilg H, Trehu E, Atkins MB, Dinarello CA, Mier JW: Interleukin-6 (IL-6) as an anti-inflammatory cytokine: induction of circulating IL-1 receptor antagonist and soluble tumor necrosis factor receptor p55. Blood 83:113, 1994